• Username (E-mail)
  • Password
Dow 19,827 0.5%  EStoxx50 3,284 -0.5%  Nikkei 18,891 -1.3%  EUR 1.0739 0.3% 
Nasdaq 5,555 0.3%  FTSE100 7,153 -0.6%  Yen 113.5080 -0.7%  Oil 55.0 -1.0% 
S&P500 2,271 0.3%  DAX 11,583 -0.4%  GBP 1.2462 0.7%  Gold 1,214 1.7% 

GlaxoSmithKline share [ISIN: GB0009252882]

Realtimequote GlaxoSmithKline plc (GSK) in GBP

Exchange Market
15.31
Last
0
Volume
Time 05:29 AM
01/23/2017 05:29:02 AM UTC-0500
activate push

Stock Price GlaxoSmithKline plc (GSK) in GBP

Activate push
15.31 GBP -0.16 GBP -1.03 %
Trade Time 10:14 AM Trade Date 1/23/2017
Daily High 15.40 Open 15.37
Daily Low 15.25 Prev. Close 15.47
52-week High 17.46 Volume (Qty.) 1,310,134
52-week Low 13.14 Market Cap (USD) 95.24 B
52-week Perf.
Exchange
The price of 15.31 GBP on the exchange London equals a price of 19.07 USD at the current exchange rate for GBP/USD.

Analyst Opinions for GlaxoSmithKline plc (GSK)

More Analyst Opinions
  • All
  • Buy
  • Hold
  • Sell
01/20/17
GlaxoSmithKline Jefferies & Company Inc.
01/19/17
GlaxoSmithKline Deutsche Bank AG
01/16/17
GlaxoSmithKline Jefferies & Company Inc.
01/12/17
GlaxoSmithKline JP Morgan Chase & Co.
01/04/17
GlaxoSmithKline JP Morgan Chase & Co.

Moody's Rating for GlaxoSmithKline plc (GSK)

Investment Grade (High Grade)
Investment Grade (Medium Grade)
Speculative Grade
Rating A2
Rating Update AFF
Date of Rating 5/29/2015
Rating Office Germany

Profile GlaxoSmithKline plc (GSK)

Company Profile
GlaxoSmithKline Plc operates as a science-led global healthcare company that researches and develops a broad range of innovative medicines and brands. It operates in three primary areas of business: Pharmaceuticals, Vaccines and Consumer Healthcare. The Pharmaceuticals business researches, develops and makes available medicines that treat a variety of serious and chronic diseases. The Vaccines business produces pediatric and adult vaccines to prevent a range of infectious diseases including, hepatitis A and B, diphtheria, tetanus and whooping cough, measles, mumps and rubella, polio, typhoid, influenza and bacterial meningitis. The Consumer Healthcare business markets a range of consumer health products based on scientific innovation. The company was founded on December 6, 1999 and is headquartered in Brentford, United Kingdom.
pagehit

Add or Edit Instrument

GlaxoSmithKline Chart - 1 Year - LSE
  • Intraday
  • 1w
  • 3 Mo.
  • 1y
  • 3y
  • 5y
  • Max
  • Exchange: LSE
  • Chart Options

Estimates for GlaxoSmithKline

2015 2016e 2017e
Dividend 1.00 0.83 0.81
Dividend Yield in % 7.24 5.33 5.20
P/E Ratio 18.26 15.41 13.93
EPS 0.76 1.01 1.11

ANALYST DATA FOR GlaxoSmithKline

Sell
Hold
Buy
12
13
14
15
16
17
18
19
20
21


GlaxoSmithKline Key Figures

Market Cap (USD) 95.24 B
Free Float in % 98.84
Number of Shares (Mio.) 4,910.11
Cash Flow per Share 0.62
Book Value per Share 1.06
60-Days Volatility 22.3
P/B Ratio 13.05

Base Data GlaxoSmithKline

Symbol
ISIN GB0009252882
Indices STOXX 50, FTSE 100, FTSE Allshare, NYSE International 100

About the Company GlaxoSmithKline

Country Great Britain

GlaxoSmithKline Historical Prices

01/19/2017
01/19/2017 06:00:00 PM UTC-0500
15.47 5,866,927
01/18/2017
01/18/2017 06:00:00 PM UTC-0500
15.53 5,917,825
01/17/2017
01/17/2017 06:00:00 PM UTC-0500
15.61 7,368,889
01/16/2017
01/16/2017 06:00:00 PM UTC-0500
15.52 6,424,123
01/15/2017
01/15/2017 06:00:00 PM UTC-0500
15.81 4,176,186

GlaxoSmithKline Peer Group

Abbott Laboratories 40.46
0.1%
Alexion Pharmaceuticals 131.97
-1.8%
Bayer 101.55
-0.6%
Celgene 112.66
-0.8%
Gilead Sciences 71.01
-0.8%
GlaxoSmithKline 15.31
-0.9%
Johnson & Johnson 114.15
0.0%
Merck 62.53
3.6%
Merck 101.50
-1.2%
Novartis 70.20
-0.8%
Pfizer 31.77
0.2%
Roche 234.90
-0.4%
STADA Arzneimittel 47.63
-0.9%
Sanofi 75.39
-0.4%
Teva Pharmaceutical Industries 33.23
-0.7%
Vertex Pharmaceuticals 81.37
0.6%